{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T20:23:07Z","timestamp":1775852587415,"version":"3.50.1"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:00:00Z","timestamp":1647129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejps.2022.106167","type":"journal-article","created":{"date-parts":[[2022,3,15]],"date-time":"2022-03-15T03:32:41Z","timestamp":1647315161000},"page":"106167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases"],"prefix":"10.1016","volume":"173","author":[{"given":"Randa","family":"Zoqlam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lazauskaite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Glickman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyubov","family":"Zaitseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petre-Cristian","family":"Ilie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1872-9572","authenticated-orcid":false,"given":"Sheng","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2022.106167_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.116528","article-title":"Chitosan-coated nanodiamonds: mucoadhesive platform for intravesical delivery of doxorubicin","volume":"245","author":"Ali","year":"2020","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0002","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1152\/physrev.00038.2003","article-title":"Urinary bladder contraction and relaxation: physiology and pathophysiology","volume":"84","author":"Andersson","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejps.2022.106167_bib0003","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2147\/TCRM.S291798","article-title":"Gene therapy for overactive bladder: a review of bk-channel \u03b1-subunit gene transfer","volume":"17","author":"Andersson","year":"2021","journal-title":"Ther. Clin. Risk Manag."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0004","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.euf.2016.11.001","article-title":"The urinary tract microbiome in health and disease","volume":"4","author":"Arag\u00f3n","year":"2018","journal-title":"Eur. Urol. Focus"},{"issue":"5","key":"10.1016\/j.ejps.2022.106167_bib0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s10038-018-0419-x","article-title":"Molecular pathogenesis of interstitial cystitis based on microRNA expression signature: miR-320 family-regulated molecular pathways and targets","volume":"63","author":"Arai","year":"2018","journal-title":"J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.ejps.2022.106167_bib0006","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1080\/17425247.2016.1182487","article-title":"Plant extracts: from encapsulation to application","volume":"13","author":"Armend\u00e1riz-Barrag\u00e1n","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.ejps.2022.106167_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cancers13092214","article-title":"Nanotechnology in bladder cancer: diagnosis and treatment","volume":"13","author":"Barani","year":"2021","journal-title":"Cancers"},{"issue":"15","key":"10.1016\/j.ejps.2022.106167_bib0008","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2022.106167_bib0009","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1152\/ajprenal.00467.2004","article-title":"More than just a barrier: urothelium as a drug target for urinary bladder pain","volume":"289","author":"Birder","year":"2005","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejps.2022.106167_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.autneu.2013.12.005","article-title":"Urinary bladder, cystitis and nerve\/urothelial interactions","volume":"182","author":"Birder","year":"2014","journal-title":"Auton. Neurosci."},{"issue":"10","key":"10.1016\/j.ejps.2022.106167_bib0011","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0012","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/nau.23489","article-title":"A genome-scale DNA methylation study in women with interstitial cystitis\/bladder pain syndrome","volume":"37","author":"Bradley","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.ejps.2022.106167_bib0013","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7402760","article-title":"Lactobacillus rhamnosus GG activation of dendritic cells and neutrophils depends on the dose and time of exposure","author":"Cai","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.ejps.2022.106167_bib0014","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/nau.22505","article-title":"Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability","volume":"33","author":"Chapple","year":"2014","journal-title":"Neurourol. Urodyn."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40846-015-0060-5","article-title":"Review: application of nanoparticles in urothelial cancer of the urinary bladder","volume":"35","author":"Chen","year":"2015","journal-title":"J. Med. Biol. Eng."},{"key":"10.1016\/j.ejps.2022.106167_bib0016","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.4111\/icu.2020.61.S1.S33","article-title":"Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis","volume":"61","author":"Chen","year":"2020","journal-title":"Investig. Clin. Urol."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0017","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/nau.23296","article-title":"MicroRNAs as potential biomarkers to predict the risk of urinary retention following intradetrusor onabotulinumtoxin-A injection","volume":"37","author":"Chermansky","year":"2018","journal-title":"Neurourol. Urodyn."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0018","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11934-004-0012-z","article-title":"Gene therapy treatments for erectile and bladder dysfunction","volume":"5","author":"Christ","year":"2004","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.ejps.2022.106167_bib0019","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1152\/ajpregu.2001.281.5.R1699","article-title":"Bladder injection of \u2018naked\u2019 hSlo\/pcDNA3 ameliorates detrusor hyperactivity in obstructed rats in vivo","volume":"281","author":"Christ","year":"2001","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0020","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0021","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","article-title":"A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome","volume":"198","author":"Chuang","year":"2017","journal-title":"J. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0022","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","article-title":"Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0023","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin a delivery using liposomes","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"issue":"8","key":"10.1016\/j.ejps.2022.106167_bib0024","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/iju.12430","article-title":"Restoring the glycosaminoglycans layer in recurrent cystitis: experimental and clinical foundations","volume":"21","author":"Cicione","year":"2014","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0025","first-page":"331","article-title":"Clinical management of bladder pain syndrome\/interstitial cystitis: a review on current recommendations and emerging treatment options","volume":"12","author":"Colemeadow","year":"2020","journal-title":"Res. Rep. Urol."},{"issue":"8","key":"10.1016\/j.ejps.2022.106167_bib0026","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/acs.molpharmaceut.8b00383","article-title":"Current therapeutic strategies in clinical urology","volume":"15","author":"Crane","year":"2018","journal-title":"Mol. Pharm."},{"issue":"7","key":"10.1016\/j.ejps.2022.106167_bib0027","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/labinvest.2008.48","article-title":"The origins of bladder cancer","volume":"88","author":"Crawford","year":"2008","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ejps.2022.106167_bib0028","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejogrb.2017.04.040","article-title":"A case controlled study examining the bladder microbiome in women with overactive bladder (OAB) and healthy controls","volume":"214","author":"Curtiss","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0029","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1152\/physrev.00041.2019","article-title":"The urothelium: life in a liquid environment","volume":"100","author":"Dalghi","year":"2020","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0030","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.maturitas.2009.09.016","article-title":"Interstitial cystitis\/bladder pain syndrome: an update","volume":"64","author":"Dasgupta","year":"2009","journal-title":"Maturitas"},{"issue":"4922","key":"10.1016\/j.ejps.2022.106167_bib0031","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1126\/science.2570461","article-title":"Molecular characterization of the human \u03b23-adrenergic receptor","volume":"245","author":"Emorine","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.ejps.2022.106167_bib0032","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s11934-005-0037-y","article-title":"Intravesical therapy for overactive bladder","volume":"6","author":"Evans","year":"2005","journal-title":"Curr. Urol. Rep."},{"issue":"11","key":"10.1016\/j.ejps.2022.106167_bib0033","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1111\/j.1464-410X.2011.10749.x","article-title":"Probiotics, dendritic cells and bladder cancer","volume":"109","author":"Feyisetan","year":"2012","journal-title":"BJU Int."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0034","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/nau.24065","article-title":"Exploring biomarkers in the overactive bladder: alterations in miRNA levels of a panel of genes in patients with OAB","volume":"38","author":"F\u0131rat","year":"2019","journal-title":"Neurourol. Urodyn."},{"issue":"12","key":"10.1016\/j.ejps.2022.106167_bib0035","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00192-018-3732-1","article-title":"Urinary symptoms are associated with certain urinary microbes in urogynecologic surgical patients","volume":"29","author":"Fok","year":"2018","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.ejps.2022.106167_bib0036","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0090-4295(99)00498-7","article-title":"Intravesical treatment of overactive bladder","volume":"55","author":"Fowler","year":"2000","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0037","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0090-4295(02)02281-1","article-title":"Intravesical liposome administration \u2013 a novel treatment for hyperactive bladder in the rat","volume":"61","author":"Fraser","year":"2003","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0038","first-page":"1","article-title":"The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy","volume":"4","author":"Fraser","year":"2002","journal-title":"Rev. Urol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0039","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s00192-012-1832-x","article-title":"Measuring the success of combined intravesical dimethyl sulfoxide and triamcinolone for treatment of bladder pain syndrome\/interstitial cystitis","volume":"24","author":"Gafni-Kane","year":"2013","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"key":"10.1016\/j.ejps.2022.106167_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2164-10-199","article-title":"Gene expression profile of bladder tissue of patients with ulcerative interstitial cystitis","volume":"10","author":"Gamper","year":"2009","journal-title":"BMC Genom."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0041","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s11884-012-0121-3","article-title":"GAG layer replenishment therapy for recurrent infectious bladder dysfunction","volume":"7","author":"Gomelsky","year":"2012","journal-title":"Curr. Bladder Dysfunct. Rep."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2022.106167_bib0042","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-5173(03)00074-7","article-title":"Influence of chitosan and polycarbophil on permeation of a model hydrophilic drug into the urinary bladder wall","volume":"256","author":"Grabnar","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0043","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.08.031","article-title":"Intravesical drug delivery: challenges, current status, opportunities and novel strategies","volume":"148","author":"GuhaSarkar","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2022.106167_bib0044","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0090-4295(97)00179-9","article-title":"Analysis of long-term elmiron therapy for interstitial cystitis","volume":"49","author":"Hanno","year":"1997","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0045","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpurol.2007.05.007","article-title":"Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children","volume":"3","author":"Hayashi","year":"2007","journal-title":"J. Pediatr. Urol."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0046","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.febslet.2010.11.031","article-title":"IL-8-induced neutrophil chemotaxis is mediated by Janus kinase 3 (JAK3)","volume":"585","author":"Henkels","year":"2011","journal-title":"FEBS Lett."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0047","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.eururo.2004.09.011","article-title":"The probiotic approach: an alternative treatment option in urology","volume":"47","author":"Hoesl","year":"2005","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.ejps.2022.106167_bib0048","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1007\/s00192-020-04593-x","article-title":"MicroRNA-495 alleviates ulcerative interstitial cystitis via inactivating the JAK\u2013STAT signaling pathway by inhibiting JAK3","volume":"32","author":"Hou","year":"2021","journal-title":"Int. Urogynecol. J."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0049","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/toxins8030059","article-title":"Botulinum toxin A for the treatment of overactive bladder","volume":"8","author":"Hsieh","year":"2016","journal-title":"Toxins"},{"issue":"8","key":"10.1016\/j.ejps.2022.106167_bib0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41585-020-0348-2","article-title":"Roles for urothelium in normal and aberrant urinary tract development","volume":"17","author":"Jackson","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107871","article-title":"Clinical therapies and nano drug delivery systems for urinary bladder cancer","volume":"226","author":"Jain","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0052","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/apha.12824","article-title":"Urothelium update: how the bladder mucosa measures bladder filling","volume":"220","author":"Janssen","year":"2017","journal-title":"Acta Physiol."},{"key":"10.1016\/j.ejps.2022.106167_bib0053","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/toxins13050359","article-title":"Novel applications of non-invasive intravesical botulinum toxin A delivery in the treatment of functional bladder disorders","author":"Jhang","year":"2021","journal-title":"Toxins"},{"issue":"10","key":"10.1016\/j.ejps.2022.106167_bib0054","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1371\/journal.pone.0076779","article-title":"Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis\/bladder pain syndrome","volume":"8","author":"Jiang","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.ejps.2022.106167_bib0055","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-014-2639-0","article-title":"Transferrin-modified PLGA nanoparticles significantly increase the cytotoxicity of paclitaxel in bladder cancer cells by increasing intracellular retention","volume":"16","author":"Jin","year":"2014","journal-title":"J. Nanopart. Res."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0056","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/brv.12034","article-title":"Glycosaminoglycans in infectious disease","volume":"88","author":"Kamhi","year":"2013","journal-title":"Biol. Rev."},{"key":"10.1016\/j.ejps.2022.106167_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2016.00078","article-title":"Does the urinary microbiome play a role in urgency urinary incontinence and its severity?","volume":"6","author":"Karstens","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.ejps.2022.106167_bib0058","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.semcancer.2019.08.014","article-title":"Natural product-based nanoformulations for cancer therapy: opportunities and challenges","volume":"69","author":"Kashyap","year":"2021","journal-title":"Semin. Cancer Biol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0059","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.juro.2013.02.090","article-title":"Down-regulation of nerve growth factor expression in the bladder by antisense oligonucleotides as new treatment for overactive bladder","volume":"190","author":"Kashyap","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lfs.2016.10.025","article-title":"Bladder overactivity involves overexpression of MicroRNA 132 and nerve growth factor","volume":"167","author":"Kashyap","year":"2016","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0061","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0192-0561(94)90116-3","article-title":"Effects of oral administration of Lactobacillus casei on antitumor responses induced by tumor resection in mice","volume":"16","author":"Kato","year":"1994","journal-title":"Int. J. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.ejps.2022.106167_bib0062","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ph14050409","article-title":"Drug delivery approaches for managing overactive bladder (OAB): a systematic review","volume":"14","author":"Khizer","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejps.2022.106167_bib0063","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.4111\/icu.2020.61.S1.S8","article-title":"Advances in urinary biomarker discovery in urological research","volume":"61","author":"Kim","year":"2020","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0064","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/uro.5000184","article-title":"Glycosaminoglycans: how much do we know about their role in the bladder?","volume":"83","author":"Klingler","year":"2016","journal-title":"Urologia"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0066","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2017.08.120","article-title":"Advances in intravesical drug delivery systems to treat bladder cancer","volume":"532","author":"Kolawole","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ejps.2022.106167_bib0067","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00192-018-3683-6","article-title":"The urinary microbiome in women with mixed urinary incotinence compared to similarly aged controls","volume":"29","author":"Komesu","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.ejps.2022.106167_bib0068","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cis.2017.06.010","article-title":"Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: a review","volume":"249","author":"Kumar","year":"2017","journal-title":"Adv. Colloid Interface Sci."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0069","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1757-5672.2009.00001.x","article-title":"Recent advances in intravesical treatment of overactive bladder","volume":"1","author":"Kuo","year":"2009","journal-title":"LUTS Low. Urin. Tract Symptoms"},{"issue":"S1","key":"10.1016\/j.ejps.2022.106167_bib0070","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/iju.12311","article-title":"Potential urine and serum biomarkers for patients with bladder pain syndrome\/interstitial cystitis","volume":"21","author":"Kuo","year":"2014","journal-title":"Int. J. Urol."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0071","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/toxins12060394","article-title":"Botulinum toxin paves the way for the treatment of functional lower urinary tract dysfunction","volume":"12","author":"Kuo","year":"2020","journal-title":"Toxins"},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0072","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.eururo.2014.01.036","article-title":"Pilot study of liposome-encapsulated onabotulinumtoxinA for patients with overactive bladder: a single-center study","volume":"65","author":"Kuo","year":"2014","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0073","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.urology.2006.04.033","article-title":"Interleukin-6, histamine, and methylhistamine as diagnostic markers for interstitial cystitis","volume":"68","author":"Lamale","year":"2006","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0074","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0056082","article-title":"Kr\u00fcppel-like factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells","volume":"8","author":"Leng","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ejps.2022.106167_bib0075","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.7150\/jca.33117","article-title":"MicroRNA-101-3p advances cisplatin sensitivity in bladder urothelial carcinoma through targeted silencing EZH2","volume":"10","author":"Li","year":"2019","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0076","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.juro.2013.08.087","article-title":"Epigenetic inactivation of KLF4 is associated with urothelial cancer progression and early recurrence","volume":"191","author":"Li","year":"2014","journal-title":"J. Urol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0077","first-page":"433","article-title":"Self-crosslinkable chitosan-hyaluronic acid dialdehyde nanoparticles for CD44-targeted siRNA delivery to treat bladder cancer","volume":"6","author":"Liang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejps.2022.106167_bib0078","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/JU.0000000000000309","article-title":"Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA\/SUFU guideline","volume":"202","author":"Lightner","year":"2019","journal-title":"J. Urol."},{"issue":"7","key":"10.1016\/j.ejps.2022.106167_bib0079","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00192-016-3232-0","article-title":"Long-term outcomes of intravesical dimethyl sulfoxide\/heparin\/hydrocortisone therapy for interstitial cystitis\/bladder pain syndrome","volume":"28","author":"Lim","year":"2017","journal-title":"Int. Urogynecol. J."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-014-0305-z","article-title":"MiR-200c inhibits invasion, migration and proliferation of bladder cancer cells through down-regulation of BMI-1 and E2F3","volume":"12","author":"Liu","year":"2014","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0081","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/TGR.0000000000000123","article-title":"Anatomy and neural control of the lower urinary tract and pelvic floor","volume":"32","author":"Livingston","year":"2016","journal-title":"Top. Geriatr. Rehabil."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0082","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-015-0515-0","article-title":"Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma","volume":"32","author":"Lou","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejps.2022.106167_bib0083","article-title":"Probiotics in cancer","volume":"11","author":"Lu","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.ejps.2022.106167_bib0084","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1742-1241.2011.02763.x","article-title":"A healthy bladder: a consensus statement","volume":"65","author":"Lukacz","year":"2011","journal-title":"Int. J. Clin. Pract."},{"issue":"7","key":"10.1016\/j.ejps.2022.106167_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.98","article-title":"Inhibition of microrna-214 promotes epithelial\u2013 mesenchymal transition process and induces interstitial cystitis in postmenopausal women by upregulating mfn2","volume":"49","author":"Lv","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"36","key":"10.1016\/j.ejps.2022.106167_bib0086","doi-asserted-by":"crossref","first-page":"60080","DOI":"10.18632\/oncotarget.19629","article-title":"1,25D3 differentially suppresses bladder cancer cell migration and invasion through the induction of miR-101-3p","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0087","first-page":"9","article-title":"Diagnosis of interstitial cystitis\/painful bladder syndrome in patients with overactive bladder symptoms","volume":"9","author":"Macdiarmid","year":"2007","journal-title":"Rev. Urol."},{"issue":"7","key":"10.1016\/j.ejps.2022.106167_bib0088","first-page":"319","article-title":"Anatomy of the lower urinary tract","volume":"31","author":"Mangera","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.ejps.2022.106167_bib0089","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/698758","article-title":"Efficient and cost-effective alternative treatment for recurrent urinary tract infections and interstitial cystitis in women: a two-case report","volume":"2014","author":"Mansour","year":"2014","journal-title":"Case Rep. Med."},{"issue":"8","key":"10.1016\/j.ejps.2022.106167_bib0090","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.nano.2013.05.017","article-title":"Nanoparticles for urothelium penetration and delivery of the histone deacetylase inhibitor belinostat for treatment of bladder cancer","volume":"9","author":"Martin","year":"2013","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"11","key":"10.1016\/j.ejps.2022.106167_bib0091","doi-asserted-by":"crossref","first-page":"27107","DOI":"10.3390\/ijms161126000","article-title":"EZH2 in bladder cancer, a promising therapeutic target","volume":"16","author":"Mart\u00ednez-Fern\u00e1ndez","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejps.2022.106167_bib0092","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2019.01125","article-title":"Epigenetics of bladder cancer: where biomarkers and therapeutic targets meet","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Genet."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0093","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/hmg\/ddp582","article-title":"Functional SNP of ARHGEF10 confers risk of atherothrombotic stroke","volume":"19","author":"Matsushita","year":"2010","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0094","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1440-1711.2000.00887.x","article-title":"Modulating immune responses with probiotic bacteria","volume":"78","author":"Matsuzaki","year":"2000","journal-title":"Immunol. Cell Biol."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","article-title":"Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal","volume":"53","author":"van de Merwe","year":"2008","journal-title":"Eur. Urol."},{"issue":"20","key":"10.1016\/j.ejps.2022.106167_bib0096","doi-asserted-by":"crossref","first-page":"33064","DOI":"10.18632\/oncotarget.16524","article-title":"MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells","volume":"8","author":"Minami","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0097","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1464-410X.2012.11282.x","article-title":"Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder (OAB)","volume":"111","author":"Mohee","year":"2013","journal-title":"BJU Int."},{"key":"10.1016\/j.ejps.2022.106167_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.phanu.2020.100219","article-title":"Lactobacillus acidophilus and Bifidobacterium longum exhibit antiproliferation, anti-angiogenesis of gastric and bladder cancer: impact of COX2 inhibition","volume":"14","author":"Nada","year":"2020","journal-title":"PharmaNutrition"},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0099","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.juro.2007.09.031","article-title":"Prevention of recurrence with epirubicin and lactobacillus casei after transurethral resection of bladder cancer","volume":"179","author":"Naito","year":"2008","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2013.12.027","article-title":"Nanoparticulation of BCG-CWS for application to bladder cancer therapy","volume":"176","author":"Nakamura","year":"2014","journal-title":"J. Control Release"},{"issue":"10","key":"10.1016\/j.ejps.2022.106167_bib0101","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","article-title":"Nanodrug delivery: is the enhanced permeability and retention effect sufficient for curing cancer?","volume":"27","author":"Nakamura","year":"2016","journal-title":"Bioconjug. Chem."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0102","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.urology.2004.10.071","article-title":"Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis","volume":"65","author":"Nickel","year":"2005","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0103","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.urols.2012.07.005","article-title":"Intravesical therapy for lower urinary tract symptoms","volume":"23","author":"Nirmal","year":"2012","journal-title":"Urol. Sci."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0104","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s00192-012-1966-x","article-title":"Interstitial cystitis patients\u2019 use and rating of complementary and alternative medicine therapies","volume":"24","author":"O'Hare","year":"2013","journal-title":"Int. Urogynecol. J. Pelvic Floor Dysfunct."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0105","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.juro.2009.11.007","article-title":"CXCR3 binding chemokine and TNFSF14 over expression in bladder urothelium of patients with ulcerative interstitial cystitis","volume":"183","author":"Ogawa","year":"2010","journal-title":"J. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0106","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000058450","article-title":"Habitual intake of lactic acid bacteria and risk raction of bladder cancer","volume":"68","author":"Ohashi","year":"2002","journal-title":"Urol. Int."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0107","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0006-291X(03)01356-1","article-title":"Downregulation and growth inhibitory effect of epithelial-type Kr\u00fcppel-like transcription factor KLF4, but not KLF5, in bladder cancer","volume":"308","author":"Ohnishi","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0108","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2147\/IJN.S38378","article-title":"Nanodrugs: pharmacokinetics and safety","volume":"9","author":"Onoue","year":"2014","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ejps.2022.106167_bib0109","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ebiom.2016.03.040","article-title":"Urinary metabolomics identifies a molecular correlate of interstitial cystitis\/bladder pain syndrome in a multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network cohort","volume":"7","author":"Parker","year":"2016","journal-title":"EBioMedicine"},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0110","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14656566.7.4.411","article-title":"Advances in the treatment of interstitial cystitis","volume":"7","author":"Parsons","year":"2006","journal-title":"Expert Opin. Pharmacother."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0111","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-5347(17)35629-X","article-title":"A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate","volume":"150","author":"Parsons","year":"1993","journal-title":"J. Urol."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0112","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ajog.2015.07.009","article-title":"The female urinary microbiome in urgency urinary incontinence","volume":"213","author":"Pearce","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01283-14","article-title":"The female urinary microbiome: a comparison of women with and without urgency urinary incontinence","volume":"5","author":"Pearce","year":"2014","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0114","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0022-5347(17)41478-9","article-title":"A controlled study of dimethyl sulfoxide in interstitial cystitis","volume":"140","author":"Perez-Marrero","year":"1988","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0115","doi-asserted-by":"crossref","first-page":"R571","DOI":"10.1152\/ajpregu.00142.2014","article-title":"Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology","volume":"307","author":"Petkov","year":"2014","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0116","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","article-title":"A Comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment","volume":"75","author":"Peyronnet","year":"2019","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejps.2022.106167_bib0117","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jconrel.2019.02.041","article-title":"Mucopenetration and biocompatibility of polydopamine surfaces for delivery in an ex vivo porcine bladder","volume":"300","author":"Poinard","year":"2019","journal-title":"J. Control Release"},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0118","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1152\/physiol.00023.2009","article-title":"Regulation of smooth muscle contraction by small GTPases","volume":"24","author":"Puetz","year":"2009","journal-title":"Physiology"},{"issue":"5","key":"10.1016\/j.ejps.2022.106167_bib0119","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.sc.3101584","article-title":"Intravesical therapy options for neurogenic detrusor overactivity","volume":"42","author":"Reitz","year":"2004","journal-title":"Spinal Cord"},{"issue":"5","key":"10.1016\/j.ejps.2022.106167_bib0120","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.eururo.2020.07.002","article-title":"FGFR3 mutation status and FGFR3 expression in a large bladder cancer cohort treated by radical cystectomy: implications for anti-FGFR3 Treatment?\u2020","volume":"78","author":"van Rhijn","year":"2020","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0121","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bpobgyn.2005.08.004","article-title":"Painful bladder syndrome\/interstitial cystitis","volume":"19","author":"Rosamilia","year":"2005","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"October 2020","key":"10.1016\/j.ejps.2022.106167_bib0122","article-title":"Doxorubicin-loaded chitosan-alginate nanoparticles with dual mucoadhesive functionalities for intravesical chemotherapy","volume":"63","author":"Sahatsapan","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1080\/00365590802671031","article-title":"Evaluation of health-related quality of life in patients with painful bladder syndrome\/interstitial cystitis and the impact of four treatments on it","volume":"43","author":"Sairanen","year":"2009","journal-title":"Scand. J. Urol. Nephrol."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0124","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/11926","article-title":"Klf4 is a transcription factor required for establishing the barrier function of the skin","volume":"22","author":"Segre","year":"1999","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0125","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1349-7006.2009.01426.x","article-title":"Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors","volume":"101","author":"Seow","year":"2010","journal-title":"Cancer Sci."},{"issue":"33","key":"10.1016\/j.ejps.2022.106167_bib0126","doi-asserted-by":"crossref","first-page":"20009","DOI":"10.1074\/jbc.271.33.20009","article-title":"Identification and characterization of a gene encoding a Gut- enriched Kr\u00fcppel-like factor expressed during growth arrest","volume":"271","author":"Shields","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejps.2022.106167_bib0127","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-11-244","article-title":"Assessing diversity of the female urine microbiota by high throughput sequencing of 16S rDNA amplicons","volume":"11","author":"Siddiqui","year":"2011","journal-title":"BMC Microbiol."},{"issue":"6264","key":"10.1016\/j.ejps.2022.106167_bib0128","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1126\/science.aac4255","article-title":"Commensal Bifidobacterium promotes antitumor","volume":"350","author":"Sivan","year":"2015","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0129","doi-asserted-by":"crossref","first-page":"9147","DOI":"10.1002\/jcb.28190","article-title":"Inhibition of microRNA-132 attenuates inflammatory response and detrusor fibrosis in rats with interstitial cystitis via the JAK-STAT signaling pathway","volume":"120","author":"Song","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.urology.2012.03.030","article-title":"Predictors of response to intravesical dimethyl-sulfoxide cocktail in patients with interstitial cystitis","volume":"80","author":"Stav","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.ejps.2022.106167_bib0131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1128\/9781683670261.ch6","article-title":"Reaching the end of the line: urinary tract infections","author":"Tamadonfar","year":"2020","journal-title":"Bact. Intracellularity"},{"issue":"7","key":"10.1016\/j.ejps.2022.106167_bib0132","first-page":"365","article-title":"The physiology and pharmacology of the lower urinary tract","volume":"37","author":"Tanabalan","year":"2019","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0133","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11884-016-0345-8","article-title":"The bladder is not sterile: history and current discoveries on the urinary microbiome compliance with ethics guidelines human and animal rights and informed consent HHS public access","volume":"11","author":"Thomas-White","year":"2016","journal-title":"Curr. Bl. Dysfunct. Rep."},{"issue":"9","key":"10.1016\/j.ejps.2022.106167_bib0134","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1517\/13543784.15.9.1017","article-title":"Current and emerging investigational medical therapies for the treatment of overactive bladder","volume":"15","author":"Tiwari","year":"2006","journal-title":"Expert Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.5980\/jpnjurol1989.85.655","article-title":"Influence of Lactobacillus casei on rat bladder carcinogenesis","volume":"85","author":"Tomita","year":"1994","journal-title":"Jpn. J. Urol."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0136","doi-asserted-by":"crossref","first-page":"159","DOI":"10.17219\/acem\/69231","article-title":"Urine nerve growth factor (NGF) level, bladder nerve staining and symptom\/problem scores in patients with interstitial cystitis","volume":"27","author":"Tonyali","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.ejps.2022.106167_bib0137","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","article-title":"Advances in bladder cancer biology and therapy","volume":"21","author":"Tran","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0138","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1517\/17460441.2014.894975","article-title":"Advances in the methods for discovering novel painful bladder syndrome therapies","volume":"9","author":"Tseng","year":"2014","journal-title":"Expert Opin. Drug Discov."},{"issue":"11","key":"10.1016\/j.ejps.2022.106167_bib0139","first-page":"485","article-title":"Kr\u00fcppel-like factor 4 is a novel prognostic predictor for urothelial carcinoma of bladder and it regulates TWIST1-mediated epithelial-mesenchymal transition","volume":"34","author":"Tseng","year":"2016","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0140","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/01.ju.0000102360.11785.d7","article-title":"Urodynamic and immunohistochemical evaluation of intravesical capsaicin delivery using thermosensitive hydrogel and liposomes","volume":"171","author":"Tyagi","year":"2004","journal-title":"J. Urol."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0141","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.2016.1100166","article-title":"Advances in intravesical therapy for urinary tract disorders","volume":"13","author":"Tyagi","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"issue":"12","key":"10.1016\/j.ejps.2022.106167_bib0142","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.ejca.2010.05.012","article-title":"MicroRNA-101 is down-regulated in gastric cancer and involved in cell migration and invasion","volume":"46","author":"Wang","year":"2010","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.ejps.2022.106167_bib0143","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1152\/ajpcell.00027.2006","article-title":"Gap junction channel activity in short-term cultured human detrusor myocyte cell pairs: gating and unitary conductances","volume":"291","author":"Wang","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0144","doi-asserted-by":"crossref","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.ejps.2022.106167_bib0145","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.3390\/cancers12123679","article-title":"Liposome-encapsulated bacillus Calmette-Guerin cell wall skeleton enhances antitumor efficiency for bladder cancer in vitro and in vivo via induction of AMP-activated protein kinase","volume":"12","author":"Whang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0146","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1128\/JCM.05852-11","article-title":"Evidence of uncultivated bacteria in the adult female bladder","volume":"50","author":"Wolfe","year":"2012","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0147","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3892\/ol.2014.1875","article-title":"MicroRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer","volume":"7","author":"Wu","year":"2014","journal-title":"Oncol. Lett."},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0148","first-page":"185","article-title":"Pathophysiology of urinary incontinence","volume":"38","author":"Wyndaele","year":"2020","journal-title":"Surgery"},{"issue":"4","key":"10.1016\/j.ejps.2022.106167_bib0149","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.3892\/or.2014.3048","article-title":"MicroRNA-10b promotes migration and invasion through KLF4 and HOXD10 in human bladder cancer","volume":"31","author":"Xiao","year":"2014","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0150","first-page":"1","article-title":"MicroRNAs with prognostic significance in bladder cancer: a systematic review and meta-analysis","volume":"7","author":"Xie","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2022.106167_bib0151","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.jconrel.2020.03.028","article-title":"Mucoadhesive nanoparticles based on ROS activated gambogic acid prodrug for safe and efficient intravesical instillation chemotherapy of bladder cancer","volume":"324","author":"Xu","year":"2020","journal-title":"J. Control Release"},{"key":"10.1016\/j.ejps.2022.106167_bib0152","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pharmthera.2018.04.010","article-title":"Basic and clinical aspects of antimuscarinic agents used to treat overactive bladder","volume":"189","author":"Yamada","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.ejps.2022.106167_bib0153","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1080\/17425247.2020.1810016","article-title":"Current status of the development of intravesical drug delivery systems for the treatment of bladder cancer","volume":"17","author":"Yoon","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2022.106167_bib0154","first-page":"S3","article-title":"Neurophysiology of lower urinary tract function and dysfunction","volume":"5","author":"Yoshimura","year":"2003","journal-title":"Rev. Urol."},{"issue":"1","key":"10.1016\/j.ejps.2022.106167_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-014-0115-4","article-title":"MicroRNA-34a functions as an anti-metastatic microRNA and suppresses angiogenesis in bladder cancer by directly targeting CD44","volume":"33","author":"Yu","year":"2014","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2022.106167_bib0156","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.omtn.2019.02.017","article-title":"lncRNA TUG1 promotes cisplatin resistance by regulating CCND2 via epigenetically silencing miR-194-5p in bladder cancer","volume":"16","author":"Yu","year":"2019","journal-title":"Mol. Ther. Nucl. Acids"},{"issue":"40","key":"10.1016\/j.ejps.2022.106167_bib0157","doi-asserted-by":"crossref","first-page":"67663","DOI":"10.18632\/oncotarget.18801","article-title":"MiR-200c inhibits bladder cancer progression by targeting lactate dehydrogenase A","volume":"8","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2022.106167_bib0158","first-page":"169","article-title":"Novel targeted bladder drug-delivery systems: a review","volume":"7","author":"Zacch\u00e8","year":"2015","journal-title":"Res. Rep. Urol."},{"issue":"9","key":"10.1016\/j.ejps.2022.106167_bib0159","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/ijc.31959","article-title":"Fermented dairy foods intake and risk of cancer","volume":"144","author":"Zhang","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ejps.2022.106167_bib0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-12-101","article-title":"The complexity of bladder cancer: long noncoding RNAs are on the stage","volume":"12","author":"Zhang","year":"2013","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.ejps.2022.106167_bib0161","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ajpath.2012.05.035","article-title":"Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling","volume":"181","author":"Zhang","year":"2012","journal-title":"Am. J. Pathol."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098722000525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:01:47Z","timestamp":1760529707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098722000525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":161,"alternative-id":["S0928098722000525"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106167","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging molecular mechanisms and genetic targets for developing novel therapeutic strategies for treating bladder diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2022.106167","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106167"}}